RecruitingNot applicableNCT05026723

Food as Medicine for HIV and Diabetes

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Seth A Berkowitz, MD, MPH
University of North Carolina, Chapel Hill
Intervention
MTM + ILI(behavioral)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2027

Study locations (1)

Collaborators

Community Servings · Massachusetts General Hospital · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05026723 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome →

← Back to all trials